| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,000 | 2,120 | 09:47 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Kooth PLC - Notice of Half Year Results | - | RNS | ||
| 12.08. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| KOOTH Aktie jetzt für 0€ handeln | |||||
| 03.08. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 31.07. | Edison Group: Edison Issues Report on Kooth (KOO) | 556 | Newsfile | London, United Kingdom--(Newsfile Corp. - July 31, 2026) - Edison issues report on Kooth (AIM: KOO)Kooth provides clinically accredited digital mental health support, focused on children and young... ► Artikel lesen | |
| 29.07. | Kooth PLC - Half Year Trading Update | - | RNS | ||
| 26.06. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | 1 | RNS | ||
| 23.06. | Kooth PLC - Result of 2026 Annual General Meeting | - | RNS | ||
| 21.05. | Kooth Digital Health Names Fred Bendaña Chief Commercial Officer | 473 | GlobeNewswire (Europe) | Chicago, May 21, 2026 (GLOBE NEWSWIRE) -- Kooth Digital Health announced the appointment of Fred Bendaña as Chief Commercial Officer, a role that will accelerate the growth of Soluna, Kooth's digital... ► Artikel lesen | |
| 19.05. | Kooth PLC - 2025 Annual Report and Notice of 2026 AGM | 1 | RNS | ||
| 19.05. | Kooth PLC - Directorate Change | - | RNS | ||
| 20.04. | Kooth PLC - 2025 Impact Report Shows Soluna's Continued Growth | 4 | RNS | ||
| 08.04. | Kooth reports lower revenue, earnings for 2025 | 14 | Sharecast | ||
| 08.04. | Kooth says annual earnings down but highlights "strong execution" | 2 | Alliance News | ||
| 08.04. | Kooth PLC Full Year Income Declines | 1 | RTTNews | ||
| 08.04. | Kooth PLC - 2025 Full Year Results | 1 | RNS | ||
| 19.03. | Kooth PLC - Notice of Full Year Results | 3 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,085 | -4,06 % | Stocks in Play: Sernova Biotherapeutics | ||
| BOSTON SCIENTIFIC | 37,405 | +0,77 % | Aktien New York Ausblick: Dow schwächelt weiter - Nasdaq stabil erwartet | NEW YORK (dpa-AFX) - Die US-Börsen steuern nach dem verlängerten Wochenende am Dienstag auf eine durchwachsene Eröffnung zu. Auf die Stimmung drückten die weiter steigenden Ölpreise, die der Angst... ► Artikel lesen | |
| PAUL HARTMANN | 199,50 | -0,25 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| VOLITIONRX | 0,337 | 0,00 % | VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, August 14 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Aug. 13, 2026 /PRNewswire/... ► Artikel lesen | |
| SYSMEX | 9,830 | +1,07 % | Sysmex Europe SE and Cytek Biosciences, Inc. Collaborate to Expand Access to Advanced Clinical Flow Cytometry | FREMONT, Calif., and HAMBURG, Germany, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in spectral... ► Artikel lesen | |
| EMBECTA | 4,744 | +12,52 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ADDLIFE | 13,490 | -3,78 % | AddLife AB: AddLife acquires Unicam Sistemas Analíticos Lda | AddLife has acquired Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment. The company will be included within AddLife's Business Area Labtech.Unicam... ► Artikel lesen | |
| ENOVIS | 16,200 | +1,89 % | Enovis auf Wells-Fargo-Konferenz: Robotik-Strategie rückt in den Mittelpunkt | ||
| PULMONX | 1,600 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 15,400 | 0,00 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,486 | -2,02 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| LIFECARE ASA | 0,011 | -57,85 % | Lifecare ASA acquires 80% of Ocean TuniCell securing established GMP manufacturing infrastructure in Bergen | ||
| BACTIGUARD | 1,285 | 0,00 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| SCIBASE | 1,505 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.09.2026 | Das Instrument 7M8 SE0003273531 ECORUB AB B EQUITY wird cum Kapitalmassnahme gehandelt am 08.09.2026 und ex Kapitalmassnahme am 09.09.2026 The instrument 7M8 SE0003273531 ECORUB AB B EQUITY is traded... ► Artikel lesen | |
| PHC HOLDINGS | 6,650 | -1,48 % | PHC Holdings Corporation: Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision... ► Artikel lesen |